Amicus Therapeutics (FOLD) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Amicus Therapeutics (FOLD) over the last 1 years, with Q3 2025 value amounting to $71000.0.
- Amicus Therapeutics' Treasury Shares fell 9992.18% to $7390.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $7390.0, marking a year-over-year decrease of 9992.18%. This contributed to the annual value of $8.3 million for FY2024, which is 1750.22% down from last year.
- Amicus Therapeutics' Treasury Shares amounted to $7390.0 in Q3 2025, which was down 9992.18% from $7390.0 recorded in Q2 2025.
- Amicus Therapeutics' 5-year Treasury Shares high stood at $10.4 million for Q2 2023, and its period low was $7390.0 during Q1 2025.
- In the last 5 years, Amicus Therapeutics' Treasury Shares had a median value of $9.5 million in 2024 and averaged $7.5 million.
- In the last 5 years, Amicus Therapeutics' Treasury Shares soared by 3236.62% in 2022 and then crashed by 9992.27% in 2025.
- Over the past 5 years, Amicus Therapeutics' Treasury Shares (Quarter) stood at $7.3 million in 2021, then surged by 32.37% to $9.7 million in 2022, then increased by 3.25% to $10.0 million in 2023, then fell by 17.5% to $8.3 million in 2024, then tumbled by 99.91% to $7390.0 in 2025.
- Its Treasury Shares was $71000.0 in Q3 2025, compared to $71000.0 in Q2 2025 and $71000.0 in Q1 2025.